Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection. (full – 2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http/www.eurekaselect.com/106175/article
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma. (abst – 2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514?dopt=Abstract
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http/www.eurekaselect.com/106175/article